Publications by authors named "Nathen Gallagher"
Introduction: There is little evidence on the ideal frequency of routine blood work in maintenance dialysis patients to manage complications, including anemia, mineral bone disease (MBD), and hyperkalemia. Recent quality improvement studies from Ontario showed no negative impacts when decreasing the frequency from monthly to every 6 weeks in conventional in-center hemodialysis (ICHD) patients. In December 2020, Alberta Kidney Care-South (AKC-S) reduced the frequency of routine blood work from every 6 weeks to every 8 weeks for ICHD patients.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigated the effects of a standardized protocol for administering recombinant tissue plasminogen activator (rt-PA) on catheter function in patients undergoing hemodialysis in Calgary, Alberta.
- - After implementing the protocol over six months, findings showed a significant reduction in rt-PA usage and catheter interventions compared to the period before the protocol, without affecting hospitalization rates or dialysis efficacy.
- - Limitations include a small sample size and the research being conducted at a single dialysis center, suggesting the need for broader studies to confirm the results.